Table 1.
Demographic and clinical data of patients at baseline
| (N = 41) | |
|---|---|
| Sex (female/male) | 39/2 |
| Age (years) | (22-63) |
| (range and mean ± s.d.) | 48 ± 10 |
| Illness duration from diagnosis (years) | (1-19) |
| (range and mean ± s.d.) | 46 ± 4.1 |
| Most frequent comorbidities [N (%)]: | |
| Temporomandibular dysfunction | 30 (73) |
| Migraine | 19 (46.3) |
| Irritable bowel syndrome | 13 (32) |
| Chronic fatigue syndrome | 7 (17.9) |
| Thyroid disease | 7 (17.9) |
| Rheumathoid arthritis | 9 (23.1) |
| Previous pharmacological treatments [N (%)]: | |
| Paracetamol | 22 (53.6) |
| NSAIDs | 27 (65.8) |
| Tramadol | 12 (29.3) |
| Benzodiazepines | 25 (60.9) |
| Antidepressants | 19 (46.3) |
| Anticonvulsants: | 3 (7.3) |
| pregabalin/gabapentin | 1 (2.4) |
| Non-pharmacological therapies [N (%)] | |
| Tai Chi | 2 (4.9) |
| Swimming pool | 2 (4.9) |
| Ozone therapy | 1 (2.4) |
| Yoga | 1 (2.4) |
| Physiotherapy | 1 (2.4 |